Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Colorectal Neoplasms 10Breast Neoplasms 10Prostatic Neoplasms 9Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Multiple Myeloma 3Lymphoma 3Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematopoietic and Lymphoid System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostate Cancer Patients 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

asciminib 4ponatinib 2nilotinib 2Dasatinib 2pegylated granulocyte colony-stimulating factor 1olverembatinib 1letermovir 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1bosutinib 1Whole-Body Irradiation 1Stem Cell Transplantation 1Specimen Handling 1Rituximab 1Practice Management, Medical 1Positron-Emission Tomography 1Melphalan 1Interviews as Topic 1Imatinib Mesylate 1Drug Monitoring 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1Busulfan 1Bone Marrow Purging 1Blood Component Removal 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myeloid, Chronic-Phase × Interviews as Topic × Clear all
NCT06229860 2026-03-10

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

University of California, Irvine

Recruiting
75 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡